Sound Vaccine
Sound Vaccine: Innovating in hearing healthcare through advanced medical systems and product manufacturing.
Sound Vaccine: Innovating in hearing healthcare through advanced medical systems and product manufacturing.
Sound Vaccine, founded with a mission to innovate in hearing healthcare, focuses on the research, development, and manufacturing of advanced hearing medical systems. The company aims to protect and enhance auditory health, particularly for professionals in the music industry. Their flagship product leverages Threshold Sound Conditioning™ Technology, clinically trialed in collaboration with esteemed institutions like Stanford University School of Medicine, to improve hearing sensitivity and maintain auditory acuity.
Notable affiliations include partnerships with distinguished research facilities such as Stanford University School of Medicine, underscoring the scientific rigor behind their technology. Key achievements include the successful clinical trials of their technology and the development of a user-friendly platform that integrates seamlessly into the daily routines of music professionals. Sound Vaccine's impact lies in its commitment to preserving the auditory health of those most at risk, ensuring that professionals can continue to perform at their best without compromising their hearing.
Companies similar to Sound Vaccine include Sound Pharmaceuticals, Hearing Health Science, Soundwave Hearing and Sonitus Medical.
Sound Vaccine's headquarters is located in Valencia, CA, US.
Sound Vaccine's most recent funding round was for ₩180B (KRW) in June 2023.
As of Jun 13, 2023, Sound Vaccine has disclosed funding of ₩180B (KRW). Undisclosed round amounts are excluded.
Sound Vaccine has 5 employees as of Feb 4, 2024.
Sonitus Medical
sonitusmedical.com
